William Blair Investment Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-439,054
Closed -$8.59M 435
2016
Q4
$8.59M Sell
439,054
-253,791
-37% -$4.6M 0.03% 321
2016
Q3
$11M Buy
692,845
+284,513
+70% +$4.37M 0.04% 307
2016
Q2
$5.77M Sell
408,332
-3,706
-0.9% -$56.5K 0.02% 343
2016
Q1
$6.93M Buy
412,038
+31,630
+8% +$556K 0.03% 324
2015
Q4
$8.54M Buy
+380,408
New +$7.84M 0.03% 301

Other funds holding ATRC

William Blair Investment Management's ATRC Position: Q1 2017 in Review

William Blair Investment Management sold out of AtriCure (ATRC) in Q1 2017, closing a stake of 439,054 shares — an estimated $8.59M sold.

William Blair Investment Management first reported a position in ATRC in Q4 2015 and held it in 5 quarters. The position peaked at $11M in Q3 2016. 99 funds tracked by Wall St. Rank hold ATRC as of Q1 2017.

  • William Blair Investment Management reported no remaining AtriCure position as of Q1 2017 after selling out during the quarter.
  • William Blair Investment Management sold 439,054 AtriCure shares in Q1 2017, an estimated $8.59M.
  • William Blair Investment Management first reported a position in AtriCure in Q4 2015 and held it in 5 quarters.
  • William Blair Investment Management's AtriCure position peaked at $11M in Q3 2016.
  • 99 funds tracked by Wall St. Rank held AtriCure as of Q1 2017.

Based on William Blair Investment Management's 13F filing for Q1 2017, filed 10 May 2017.